125 related articles for article (PubMed ID: 9793480)
21. [Cytostatic action of semisynthetic derivatives of carminomycin].
Volkolupova OP; Makukho LV
Antibiotiki; 1982 Feb; 27(2):145-7. PubMed ID: 7065650
[TBL] [Abstract][Full Text] [Related]
22. [Acute toxicity of the N-acyl derivatives of carminomycin and rubomycin].
Shepelevtsev NG; Gol'dberg LE; Olsuf'eva EN; Povarov LS
Antibiotiki; 1982 Jan; 27(1):57-61. PubMed ID: 7059147
[TBL] [Abstract][Full Text] [Related]
23. [Synthesis and antitumor action of 14-N-substituted derivatives of rubomycin and karminomycin].
Olsuf'eva EN; Povarov LS; Salimova EI; Volkolupova OP; Makukho LV
Antibiot Med Biotekhnol; 1987 Apr; 32(4):254-9. PubMed ID: 3631931
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase.
Hernick M; Flader C; Borch RF
J Med Chem; 2002 Aug; 45(16):3540-8. PubMed ID: 12139465
[TBL] [Abstract][Full Text] [Related]
25. N-(2,2-Dimethyl-2-(2-nitrophenyl)acetyl)-4-aminocyclophosphamide as a potential bioreductively activated prodrug of phosphoramide mustard.
Jiang Y; Hu L
Bioorg Med Chem Lett; 2008 Jul; 18(14):4059-63. PubMed ID: 18556201
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
Struck RF; Schmid SM; Waud WR
Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
[TBL] [Abstract][Full Text] [Related]
27. [Anthracycline antibiotics and their derivatives--inhibitors of topoisomerase I].
Dezhenkova LG; Teviashova AN; Olsuf'eva EN; Treshchalin ID; Shtil' AA; Preobrazhenskaia MN
Bioorg Khim; 2008; 34(3):430-2. PubMed ID: 18672696
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of nitroheterocyclic phosphoramidates as hypoxia-selective alkylating agents.
Borch RF; Liu J; Schmidt JP; Marakovits JT; Joswig C; Gipp JJ; Mulcahy RT
J Med Chem; 2000 Jun; 43(11):2258-65. PubMed ID: 10841804
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antineoplastic activity of a novel series of phosphoramide mustard analogues of pyrimidine deoxyribonucleosides.
Lin TS; Fischer PH; Prusoff WH
J Med Chem; 1980 Nov; 23(11):1235-7. PubMed ID: 7452673
[TBL] [Abstract][Full Text] [Related]
30. An improved synthesis of lysosomal activated mustard prodrug for tumor-specific activation and its cytotoxic evaluation.
Adidala R; Devalapally H; Srivari C; Devarakonda R K; Akkinepally RR
Drug Dev Ind Pharm; 2012 Sep; 38(9):1047-53. PubMed ID: 22185667
[TBL] [Abstract][Full Text] [Related]
31. [Antitumor antibiotics of the anthracycline series and their semisynthetic derivatives].
Povarov LS
Antibiotiki; 1977 Jul; 22(7):653-67. PubMed ID: 883809
[No Abstract] [Full Text] [Related]
32. Design, synthesis and biological evaluation of quinazoline-phosphoramidate mustard conjugates as anticancer drugs.
Lin S; Li Y; Zheng Y; Luo L; Sun Q; Ge Z; Cheng T; Li R
Eur J Med Chem; 2017 Feb; 127():442-458. PubMed ID: 28092860
[TBL] [Abstract][Full Text] [Related]
33. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
Kwon CH; Moon KY; Baturay N; Shirota FN
J Med Chem; 1991 Feb; 34(2):588-92. PubMed ID: 1995881
[TBL] [Abstract][Full Text] [Related]
34. The synthesis of epsilon-rhodomycinone- and carminomycin-11-methyl ethers.
Essery JM; Doyle TW
J Antibiot (Tokyo); 1979 Mar; 32(3):247-9. PubMed ID: 457585
[TBL] [Abstract][Full Text] [Related]
35. [Determination of carminomycin in its preparations by high-performance liquid chromatography].
Aleksandrova LG; Rubasheva LM; Zbarskiĭ VB; Brazhnikova MG
Antibiot Khimioter; 1988 Aug; 33(8):574-8. PubMed ID: 3196114
[TBL] [Abstract][Full Text] [Related]
36. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
Jain M; Fan J; Baturay NZ; Kwon CH
J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
[TBL] [Abstract][Full Text] [Related]
37. Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.
Cassinelli G; Grein A; Masi P; Suarato A; Bernardi L; Arcamone F; Di Marco A; Casazza AM; Pratesi G; Soranzo C
J Antibiot (Tokyo); 1978 Mar; 31(3):178-84. PubMed ID: 649513
[TBL] [Abstract][Full Text] [Related]
38. [Suppression of DNA synthesis in mice by the anthracycline antibiotics daunorubicin, carminomycin and doxorubicin].
Reznikova MI; Dudnik IuV
Antibiot Khimioter; 1988 Apr; 33(4):286-9. PubMed ID: 3389958
[TBL] [Abstract][Full Text] [Related]
39. [Determination of carminomycin and its basic metabolite 13-dihydrocarminomycin by a highly efficient liquid chromatographic method with a fluorescent detector].
Poteshnykh AV; Shevchenko VE
Antibiotiki; 1982 Nov; 27(11):820-3. PubMed ID: 7181464
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent.
Seker H; Bertram B; Bürkle A; Kaina B; Pohl J; Koepsell H; Wiesser M
Br J Cancer; 2000 Feb; 82(3):629-34. PubMed ID: 10682676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
